Pdt Partners, LLC Evolus, Inc. Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$9.99 - $14.91 $4,065 - $6,068	407 Added 0.63%	64,741 $906,000
Q2 2023 Aug 14, 2023	BUY	$7.23 - $10.52 $205,368 - $298,820	28,405 Added 79.06%	64,334 $467,000
Q1 2023 May 15, 2023	BUY	$7.81 - $11.05 $280,605 - $397,015	35,929 New	35,929 $303,000
Q1 2021 May 17, 2021	SELL	$3.2 - $16.51 $62,688 - $323,430	-19,590 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.03 - $5.48 $224 - $405	-74 Reduced 0.38%	19,590 $77,000
Q2 2020 Aug 14, 2020	BUY	$3.53 - $6.17 $69,413 - $121,326	19,664 New	19,664 $104,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.